On Invalid Date, Mereo Biopharma Group (NASDAQ: MREO) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Mereo Biopharma Group earnings for the quarter were N/A. In the same quarter last year, Mereo Biopharma Group's earnings per share (EPS) was N/A.
As of Q2 2024, Mereo Biopharma Group's earnings has grown year over year. Mereo Biopharma Group's earnings in the past year totalled -$29.47 million.
What is MREO's earnings date?
Mereo Biopharma Group's earnings date is Invalid Date. Add MREO to your watchlist to be reminded of MREO's next earnings announcement.
What was MREO's revenue last quarter?
On Invalid Date, Mereo Biopharma Group (NASDAQ: MREO) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Mereo Biopharma Group's revenue was N/A.
What was MREO's revenue growth in the past year?
As of Q2 2024, Mereo Biopharma Group's revenue has grown null year over year. Mereo Biopharma Group's revenue in the past year totalled $10.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.